Royce Smaller-Companies Growth Fund Service (RYVPX)
7.86
+0.04
(+0.51%)
USD |
Jun 02 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.49% | 183.35M | 0.30% | 73.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -28.53M | 18.44% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital. The Fund invests at least 80% of its net assets in equity securities of companies with stock market capitalizations up to $7.5 billion. The Fund may continue to hold or, in some cases, build positions in companies with market capitalizations of more than $7.5 billion. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Growth Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Royce Investment Partners |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
51
-554.21M
Peer Group Low
121.98M
Peer Group High
1 Year
% Rank:
48
-28.53M
-2.110B
Peer Group Low
1.468B
Peer Group High
3 Months
% Rank:
44
-894.35M
Peer Group Low
218.13M
Peer Group High
3 Years
% Rank:
48
-3.528B
Peer Group Low
3.956B
Peer Group High
6 Months
% Rank:
43
-1.003B
Peer Group Low
793.02M
Peer Group High
5 Years
% Rank:
52
-8.195B
Peer Group Low
4.236B
Peer Group High
YTD
% Rank:
42
-920.45M
Peer Group Low
717.74M
Peer Group High
10 Years
% Rank:
72
-12.77B
Peer Group Low
4.238B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of June 03, 2025.
Asset Allocation
As of March 31, 2025.
| Type | % Net |
|---|---|
| Cash | 5.10% |
| Stock | 94.90% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Fixed Income Clearing Corp Repo
|
4.04% | -- | -- |
| Corcept Therapeutics Inc | 3.17% | 69.56 | -2.95% |
| Guardian Pharmacy Services Inc | 2.95% | 21.78 | 2.33% |
| Life Time Group Holdings Inc | 2.71% | 29.18 | -1.59% |
| ACV Auctions Inc | 2.62% | 16.34 | 1.05% |
| Cantaloupe Inc | 2.28% | 8.765 | 0.06% |
| Abacus Global Management Inc | 2.20% | 7.635 | 0.33% |
| ARS Pharmaceuticals Inc | 2.05% | 14.54 | 0.55% |
| Mirion Technologies Inc | 2.04% | 19.41 | 0.73% |
| VSE Corp | 1.99% | 131.24 | 0.81% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.25% |
| Actual Management Fee | 0.92% |
| Administration Fee | 64.16K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 2000.00 None |
| Minimum Subsequent Investment | 50.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital. The Fund invests at least 80% of its net assets in equity securities of companies with stock market capitalizations up to $7.5 billion. The Fund may continue to hold or, in some cases, build positions in companies with market capitalizations of more than $7.5 billion. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Growth Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Royce Investment Partners |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (6-2-25) | 0.81% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 40.18 |
| Weighted Average Price to Sales Ratio | 7.395 |
| Weighted Average Price to Book Ratio | 6.430 |
| Weighted Median ROE | -16.21% |
| Weighted Median ROA | -2.49% |
| ROI (TTM) | -3.30% |
| Return on Investment (TTM) | -3.30% |
| Earning Yield | 0.0300 |
| LT Debt / Shareholders Equity | 2.835 |
As of March 31, 2025
Growth Metrics
| EPS Growth (1Y) | 29.47% |
| EPS Growth (3Y) | 21.92% |
| EPS Growth (5Y) | 22.38% |
| Sales Growth (1Y) | 20.68% |
| Sales Growth (3Y) | 24.41% |
| Sales Growth (5Y) | 19.71% |
| Sales per Share Growth (1Y) | 6.17K% |
| Sales per Share Growth (3Y) | 25.49% |
| Operating Cash Flow - Growth Ratge (3Y) | 38.56% |
As of March 31, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:RYVPX", "name") |
| Broad Asset Class: =YCI("M:RYVPX", "broad_asset_class") |
| Broad Category: =YCI("M:RYVPX", "broad_category_group") |
| Prospectus Objective: =YCI("M:RYVPX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |